Anti-proliferative effect of Flos Albiziae flavonoids on the human gastric cancer SGC-7901 cell line

Experimental and Therapeutic Medicine

Volumn 5, Issue 1, 2013, Pages 51-56

  Yuan, Jianmei ^a   Li, Wanli ^a   Tian, Yuhui ^a   Wang, Xia ^a  

^a XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle arrest; Flos Albiziae flavonoids; Human gastric cancer SGC 7901 cell line; Proliferation

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; FLAVONOID; PROTEIN BAX; PROTEIN BCL 2; SYNAPTOTAGMIN I;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLOS ALBIZIAE; HERB; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; STOMACH CANCER;

EID: 84869443584     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.771     Document Type: Article

References (22)

1. Aiyegoro OA and Okoh AI: Phytochemical screening and poly-phenolic antioxidant activity of aqueous crude leaf extract of Helichrysum pedunculatum. Int J Mol Sci 10: 4990-5001, 2009.
2. Katayama K, Masuyama K, Yoshioka S, Hasegawa H, Mitsuhashi J and Sugimoto Y: Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specifcity and structure-activity relationship. Cancer Chemother Pharmacol 60: 789-797, 2007.
3. Surh YJ: Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3: 768-780, 2003.
4. Tan AC, Konczak I, Ramzan I, Zabaras D and Sze DM: Potential antioxidant, antiinflammatory, and proapoptotic anticancer activities of Kakadu plum and Illawarra plum polyphenolic fractions. Nutr Cancer 63: 1074-1084, 2011.
5. Youn UJ, Nam KW, Kim HS, Choi G, Jeong WS, Lee MY and Chae S: 3-Deoxysappanchalcone inhibits tumor necrosis factor-α-induced matrix metalloproteinase-9 expression in human keratinocytes through activated protein-1 inhibition and nuclear factor-kappa B DNA binding activity. Biol Pharm Bull 34: 890-893, 2011.
6. Muthee JK, Gakuya DW, Mbaria JM, Kareru PG, Mulei CM and Njonge FK: Ethnobotanical study of anthelmintic and other medicinal plants traditionally used in Loitoktok district of Kenya. J Ethnopharmacol 135: 15-21, 2011.
7. Lacaille-Dubois M-A, Pegnyemb DE, Noté OP and Mitaine-Offer A-C: A review of acacic acid-type saponins from Leguminosae-Mimosoideae as potent cytotoxic and apoptosis inducing agents. Phytochem Rev 10: 565-584, 2011.
8. Chen J, Li Y, Yang LQ, Li YZ, Nan ZB and Gao K: Biological activities of favonoids from pathogenic-infected Astragalus adsurgens. Food Chem 131: 546-551, 2012.
9. Martini ND, Katerere DR and Eloff JN: Biological activity of fve antibacterial favonoids from Combretum erythrophyllum (Combretaceae). J Ethnopharmacol 93: 207-212, 2004.
10. Sun L, Zhang J, Lu X, Zhang L and Zhang Y: Evaluation to the antioxidant activity of total favonoids extract from persimmon (Diospyros kaki L.) leaves. Food Chem Toxicol 49: 2689-2696, 2011.
11. Weyerbrock A, Walbridge S, Saavedra JE, Keefer LK and Oldfeld EH: Differential effects of nitric oxide on blood-brain barrier integrity and cerebral blood flow in intracerebral C6 gliomas. Neuro Oncol 13: 203-211, 2011.
12. Robinson ES, Khankin EV, Choueiri TK, Dhawan MS, Rogers MJ, Karumanchi SA and Humphreys BD: Suppression of the nitric oxide pathway in metastatic renal cell carcinoma patients receiving vascular endothelial growth factor-signaling inhibitors. Hypertension 56: 1131-1136, 2010.
13. Miyanaga N, Akaza H, Hinotsu S, et al: Prostate cancer chemo-prevention study: An investigative randomized control study using purifed isofavones in men with rising prostate-specifc antigen. Cancer Sci 103: 125-130, 2012.
14. Setchell KD, Brown NM, Zhao X, Lindley SL, Heubi JE, King EC and Messina MJ: Soy isofavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk. Am J Clin Nutr 94: 1284-1294, 2011.
15. Kelly MG, Mor G, Husband A, O'Malley DM, Baker L, Azodi M, Schwartz PE and Rutherford TJ: Phase II evaluation of phenoxodiol in combination with cisplatin or paclitaxel in women with platinum/taxane-refractory/resistant epithelial ovarian, fallopian tube, or primary peritoneal cancers. Int J Gynecol Cancer 21: 633-639, 2011.
16. Shanmugam MK, Kannaiyan R and Sethi G: Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer. Nutr Cancer 63: 161-173, 2011.
17. Liu YL, Tang LH, Liang ZQ, You BG and Yang SL: Growth inhibitory and apoptosis inducing by effects of total favonoids from Lysimachia clethroides Duby in human chronic myeloid leukemia K562 cells. J Ethnopharmacol 131: 1-9, 2010.
18. Kim JH, Kang J W, Kim MS, et al: The apoptotic effects of the favonoid N101-2 in human cervical cancer cells. Toxicol In Vitro 26: 67-73, 2012.
19. Lanigan F, Gremel G, Hughes R, Brennan DJ, Martin F, Jirström K and Gallagher WM: Homeobox transcription factor muscle segment homeobox 2 (Msx2) correlates with good prognosis in breast cancer patients and induces apoptosis in vitro. Breast Cancer Res 12: R59, 2010.
20. Debatin KM: Apoptosis pathways in cancer and cancer therapy. Cancer Immunol Immunother 53: 153-159, 2004.
21. Watatani M, Ieda S, Kuroda K, Inui H, Nishimura K and Yasutomi M: Comparison of p53 and bcl-2 expression in initial, synchronous, and metachronous colorectal adenomas. Surg Today 29: 707-712, 1999.
22. Aisenbrey C, Sudheendra US, Ridley H, et al: Helix orientations in membrane-associated Bcl-X(L) determined by 15N-solid-state NMR spectroscopy. Eur Biophys J 37: 71-80, 2007.